Second primary tumor in patients with upper aerodigestive tract cancer

Brazilian Journal of Otorhinolaryngology

Volumn 76, Issue 2, 2010, Pages 251-256

  Priante, Antonio Vitor Martins ^a   Carvalho, Andre Lopes ^b   Kowalski, Luiz Paulo ^c  

^a UNIVERSITY OF TAUBATÉ   (Brazil)

^b Cancer Hospital   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Head and neck neoplasms; Neoplasms; Second primary tumor

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SECOND CANCER; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77957338137     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1590/S1808-86942010000200017     Document Type: Article

References (31)

1. Cancer Facts & Figures 2008 [online]. Atlanta: American Cancer Society; 2008 [cited 2008 Mar 71. Available from: http://www.cancer. org/docroot/STT/content/STT-1x-Cancer-Facts-and-Figures-2008. asp.
2. Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Radiation therapy for squamous cell carcinome of the tonsillar region: a preferred alternative to surgery? J Clin Oncol. 2000; 18: 2219-25. (Pubitemid 30350213)
3. Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Moore-Higgs GJ, Cassisi NJ. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol. 2000; 18: 35-42. (Pubitemid 30036334)
4. Gehanno P, Dependt J, Guedon C, Kebaili C, Koka V. Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients. Head Neck. 1993; 15: 185-9. (Pubitemid 23122098)
5. Cooney TR, Poulsen MG. Is routine follow-up useful after combinedmodality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg. 1999; 125: 379-82. (Pubitemid 29169763)
6. de Visscher AVM, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: does it make sense? Arch Otolaryngol Head Neck Surg. 1994; 120: 934-9. (Pubitemid 24287708)
7. Snow GB. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for long? Eur J Cancer. 1992; 28: 315-6.
8. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001; 258: 177-83. (Pubitemid 32467743)
9. Boysen M, Natvig K, Winther FO, Tausjö J. Value of routine followup in patients treated for squamous cell carcinoma of the head and neck. J Otolaryngol. 1985; 14: 211-4. (Pubitemid 15008776)
10. Boysen M, Lövdal O, Tausjö J, Winther FO. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992; 28: 426-30.
11. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002; 128: 58-62. (Pubitemid 34052086)
12. Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis. 2003; 9: 112-8. (Pubitemid 36648132)
13. Vikram B, Strong EW, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg. 1984; 6: 734-7. (Pubitemid 14185491)
14. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995; 104: 946-54.
15. Warren S; Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932; 16: 1358-403.
16. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer. 1953; 6: 963-8.
17. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer. 1992; 70: 14-9.
18. Hamada GS, Nishimoto IN, Torloni H. Registro hospitalar de câncer: estatística de 1994. (Monografias do Registro Hospitalar de Câncerl. São Paulo: Hospital A. C. Camargo, Pro-Onco; 1996.
19. American Joint Committee on Cancer. AJCC cancer staging manual, 6th ed. New York: Springer; 2002.
20. SPSSI. Statistical package for social science, statistical data analysis for Windows. Chicago, Illinois: SPSS Inc; 2000.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Static Assoc. 1958; 53: 457-81.
22. Di Martino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol. 2002; 116: 831-8. (Pubitemid 35178012)
23. Franco EL, Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol. 1991; 44.615-25.
24. Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003; 98: 765-72. (Pubitemid 36959273)
25. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck. 1999; 21: 204-10. (Pubitemid 29144579)
26. Parker RG, Hill JH. Panendoscopy in screening for synchronous primary malignancies. Laryngoscope. 1988; 98: 14-9.
27. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic Screening protocol Ann Otol Rhinol Laryngol. 1992; 101: 105-12.
28. ujala K, Sipilȧ J, Grenman R. Panendoscopy and synchronous second primary tumors in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2005; 262: 17-20.
29. Murakami S, Hashimoto T, Noguchi T, Hazamada S, Uchida Y, Suzuki M, et al. The utility of endoscopic screening for patients with esophageal or head and neck cancer. Dis Esophagus. 1999; 12: 186-90. (Pubitemid 30021389)
30. Tincani AJ, Brandalise N, Andreollo NA, Lopes LR, Montes CG, Altemani A, Martins AS. Importance of upper digestive endoscopy using lugol dye solution for the diagnosis of superficial esophageal cancer and dysplasia in patients with head and neck neoplasms. Arq Gastroenterol. 2000; 37: 107-13.
31. Guardiola E, Chaigneau L, Villanueva C, Pivot X. Is there still a role for triple endoscopy as part of staging for head and neck cancer? Curr Opin Otolaryngol Head Neck Surg. 2006; 14: 85-8.